echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > How to resist cognitive decline in the brain? Research discovers new treatment targets

    How to resist cognitive decline in the brain? Research discovers new treatment targets

    • Last Update: 2021-12-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    With advances in medical and health care, the average life span of human beings has continued to increase in the past few decades


    However, there is also a small group of lucky patients who can resist cognitive decline caused by age and pathological changes


    Recently, the team of Professor Lihui Cai from the Massachusetts Institute of Technology found a key protein whose activity may explain how cognitive flexibility comes from


    This positive result points out the direction for the development of new therapies, and related papers were recently published in Science Translational Medicine, a subsidiary of Science


    This new discovery by scientists is not accidental, but is based on a phenomenon observed and proven by researchers and clinicians over the past years, that is, the more colorful the environment, the more protective the brain


    In animal experiments, if the mice are allowed to live in a cage with a lot of toys and a larger space for activity, their cognitive flexibility will be better than those of mice with a monotonous living environment


    ▲Schematic diagram of mouse experiment: Different environments with different levels of abundance have different effects on cognitive performance (picture source: reference [1])

    After a series of comparisons and analyses, a transcription factor called MEF2 emerged


    ▲Human data from the two cohorts show that there is a correlation between the expression of MEF2 in the prefrontal lobe of the brain and the overall cognitive function (picture source: reference [1])

    Following this discovery, the researchers proposed a potential strategy to improve cognitive flexibility: increasing the activity of MEF2


    Although the pathological tau protein in these mice, a characteristic pathological protein of Alzheimer’s disease, has not been eliminated, the overexpression of Mef2 gene is sufficient to protect the mice’s neurons and reduce the incidence of neurodegenerative diseases.


    Note: The original text has been deleted

    Reference materials:

    [1] Scarlett J.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.